Peter Steinberger

30PUBLICATIONS
109CO-AUTHORS
Medical infection agents (incl. prions)Cellular immunologyPlant pathologyInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Mar 16, 2026
Bifunctional glycolipids targeting TLR4·MD-2 and short pentraxins.

Daniele Zucchetta, Lena Nuschy, Simon Gumpelmair

|Nov 30, 2025
CD160-Derived Peptide as a Bidirectional Inhibitor Toward Immune Checkpoints BTLA/HVEM and HVEM/LIGHT.

Magdalena Lipińska, Piotr Ciura, Simon Gumpelmair

|Mar 22, 2025
An engineered PD1-Fc fusion produced in N. benthamiana plants efficiently blocks PD1/PDL1 interaction.

Shiva Izadi, Rafaela Abrantes, Simon Gumpelmair

|Mar 14, 2025
HLA-E/peptide complexes differentially interact with NKG2A/CD94 and T cell receptors.

Linda Voogd, Remco L van den Broek, Marjolein van Wolfswinkel

|Nov 19, 2024
LAG-3-An incompletely understood target in cancer therapy.

Judith Leitner, Katharina Aigner-Radakovics, Peter Steinberger

Pageof 5